In patients with COPD GOLD II and III with a predominance of Th1 immunoregulatory pathway, the relative number of peripheral blood CD4+CD282+ cells was statistically significantly elevated by 68% (p < 0.05) and 92% (p < 0.05), respectively, compared to the control group. This evidence concerns the gene TLR2 and chronic obstructive pulmonary disease.